Sarcoma GOG 261

March 13, 2013

Location: The Hospital of Central Connecticut

A Randomized Phase III Trial of Paclitaxel plus Carboplatin versus Ifosfamide plus Paclitaxel in Chemotherapy-Naïve Patients with Newly Diagnosed Stage I-IV Persistent or
Recurrent Carcinosarcoma (Mixed Mesodermal Tumors).